Clinical Trial Update: Innovative Central Line Securement Device in the Pediatric Population [NA]

View source ↗

Summary

A pediatric trial evaluating an innovative central line securement device was terminated. Results were posted on July 5, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Line-associated Bloodstream Infection
• Short Bowel Syndrome

Snippet

Sponsor: Ryan St. Pierre-Hetz | Conditions: Central Line Complication, Central Line Infection | NA | Status: TERMINATED | Results posted: 2024-07-05